|
1.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2.
|
Wright MD, Ni J and Rudy GB: The L6
membrane proteins - a new four-transmembrane superfamily. Protein
Sci. 9:1594–1600. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Allioli N, Vincent S, Vlaeminck-Guillem V,
Decaussin-Petrucci M, Ragage F, Ruffion A and Samarut J: TM4SF1, a
novel primary androgen receptor target gene over-expressed in human
prostate cancer and involved in cell migration. Prostate.
71:1239–1250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Hellstrom I, Horn D, Linsley P, Brown JP,
Brankovan V and Hellstrom KE: Monoclonal mouse antibodies raised
against human lung carcinoma. Cancer Res. 46:3917–3923.
1986.PubMed/NCBI
|
|
5.
|
Chang YW, Chen SC, Cheng EC, Ko YP, Lin
YC, Kao YR, Tsay YG, Yang PC, Wu CW and Roffler SR: CD13
(amino-peptidase N) can associate with tumor-associated antigen L6
and enhance the motility of human lung cancer cells. Int J Cancer.
116:243–252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Lekishvili T, Fromm E, Mujoomdar M and
Berditchevski F: The tumour-associated antigen L6 (L6-Ag) is
recruited to the tetraspanin-enriched microdomains: implication for
tumour cell motility. J Cell Sci. 121:685–694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kao YR, Shih JY, Wen WC, Ko YP, Chen BM,
Chan YL, Chu YW, Yang PC, Wu CW and Roffler SR: Tumor-associated
antigen L6 and the invasion of human lung cancer cells. Clin Cancer
Res. 9:2807–2816. 2003.PubMed/NCBI
|
|
8.
|
Cao J, Ramachandran V, Arumugam T, Nast F
and Logsdon C: TM4SF1 stimulates pancreatic cancer cell migration
and invasion. Pancreas. 38:9862009.
|
|
9.
|
Ying SY, Chang DC and Lin SL: The microRNA
(miRNA): overview of the RNA genes that modulate gene function. Mol
Biotechnol. 38:257–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Wang F, Xue X, Wei J, An Y, Yao J, Cai H,
Wu J, Dai C, Qian Z, Xu Z and Miao Y: hsa-miR-520h downregulates
ABCG2 in pancreatic cancer cells to inhibit migration, invasion,
and side populations. Br J Cancer. 103:567–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Aguda BD, Kim Y, Piper-Hunter MG, Friedman
A and Marsh CB: MicroRNA regulation of a cancer network:
consequences of the feedback loops involving miR-17-92, E2F, and
Myc. Proc Natl Acad Sci USA. 105:19678–19683. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Grady WM, Parkin RK, Mitchell PS, Lee JH,
Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz
AM, Kroh EM, Allen A, Fritz BR, Markowitz SD and Tewari M:
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its
host gene EVL in colorectal cancer. Oncogene. 27:3880–3888. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gandellini P, Folini M, Longoni N, Pennati
M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta
P, Valdagni R, Daidone MG and Zaffaroni N: miR-205 exerts
tumor-suppressive functions in human prostate through
down-regulation of protein kinase Cepsilon. Cancer Res.
69:2287–2295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Hoffman AE, Zheng T, Yi C, Leaderer D,
Weidhaas J, Slack F, Zhang Y, Paranjape T and Zhu Y: microRNA
miR-196a-2 and breast cancer: a genetic and epigenetic association
study and functional analysis. Cancer Res. 69:5970–5977. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT,
Goan YG and Lu PJ: MicroRNA-330 acts as tumor suppressor and
induces apoptosis of prostate cancer cells through E2F1-mediated
suppression of Akt phosphorylation. Oncogene. 28:3360–3370. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Aqeilan RI, Calin GA and Croce CM: miR-15a
and miR-16-1 in cancer: discovery, function and future
perspectives. Cell Death Differ. 17:215–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H,
Calin GA, Menard S and Croce CM: MicroRNA signatures in human
ovarian cancer. Cancer Res. 67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Bandres E, Cubedo E, Agirre X, Malumbres
R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M and
Garcia-Foncillas J: Identification by Real-time PCR of 13 mature
microRNAs differentially expressed in colorectal cancer and
non-tumoral tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Pallante P, Visone R, Ferracin M, Ferraro
A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M,
Negrini M, Croce CM and Fusco A: MicroRNA deregulation in human
thyroid papillary carcinomas. Endocr Relat Cancer. 13:497–508.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kent OA, Mullendore M, Wentzel EA,
Lopez-Romero P, Tan AC, Alvarez H, West K, Ochs MF, Hidalgo M,
Arking DE, Maitra A and Mendell JT: A resource for analysis of
microRNA expression and function in pancreatic ductal
adenocarcinoma cells. Cancer Biol Ther. 8:2013–2024.
2009.PubMed/NCBI
|
|
22.
|
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma
J, Wu M, Zhou M, Shen S, Niu Z, Zhang W, Shi L, Xiang B, Lu J, Wang
L, Li D, Tang H and Li G: microRNA-141 is involved in a
nasopharyngeal carcinoma-related genes network. Carcinogenesis.
31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Amaral FC, Torres N, Saggioro F, Neder L,
Machado HR, Silva WA Jr, Moreira AC and Castro M: MicroRNAs
differentially expressed in ACTH-secreting pituitary tumors. J Clin
Endocrinol Metab. 94:320–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Meng F, Henson R, Lang M, Wehbe H,
Maheshwari S, Mendell JT, Jiang J, Schmittgen TD and Patel T:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Snowdon J, Zhang X, Childs T, Tron VA and
Feilotter H: The microRNA-200 family is upregulated in endometrial
carcinoma. PLoS One. 6:e228282011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T
and Si J: Down-regulation of miR-141 in gastric cancer and its
involvement in cell growth. J Gastroenterol. 44:556–561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Nakada C, Matsuura K, Tsukamoto Y,
Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida
T, Sato F, Mimata H, Seto M and Moriyama M: Genome-wide microRNA
expression profiling in renal cell carcinoma: significant
down-regulation of miR-141 and miR-200c. J Pathol. 216:418–427.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Janes SM and Watt FM: New roles for
integrins in squamous-cell carcinoma. Nat Rev Cancer. 6:175–183.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Shih SC, Zukauskas A, Li D, Liu G, Ang LH,
Nagy JA, Brown LF and Dvorak HF: The L6 protein TM4SF1 is critical
for endothelial cell function and tumor angiogenesis. Cancer Res.
69:3272–3277. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Maecker HT, Todd SC and Levy S: The
tetraspanin superfamily: molecular facilitators. FASEB J.
11:428–442. 1997.PubMed/NCBI
|
|
32.
|
Baffa R, Fassan M, Volinia S, O’Hara B,
Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM and
Rosenberg A: MicroRNA expression profiling of human metastatic
cancers identifies cancer gene targets. J Pathol. 219:214–221.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Neves R, Scheel C, Weinhold S, Honisch E,
Iwaniuk KM, Trompeter HI, Niederacher D, Wernet P, Santourlidis S
and Uhrberg M: Role of DNA methylation in miR-200c/141 cluster
silencing in invasive breast cancer cells. BMC Res Notes.
3:2192010. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Hu M, Xia M, Chen X, Lin Z, Xu Y, Ma Y and
Su L: MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and
inhibits migration and invasion of colorectal cancer cells. Dig Dis
Sci. 55:2365–2372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Mateescu B, Batista L, Cardon M, Gruosso
T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P,
Sastre-Garau X and Mechta-Grigoriou F: miR-141 and miR-200a act on
ovarian tumorigenesis by controlling oxidative stress response. Nat
Med. 17:1627–1635. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Morales-Prieto DM, Schleussner E and
Markert UR: Reduction in miR-141 is induced by leukemia inhibitory
factor and inhibits proliferation in choriocarcinoma cell line
JEG-3. Am J Reprod Immunol. 66(Suppl 1): 57–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
